Use and Outcomes of SBRT for Early Stage NSCLC Without Pathologic Confirmation in the Veterans Health Care Administration.

Wilkie, Joel R; Lipson, Rachel; Johnson, Matthew C; Williams, Christina; Moghanaki, Drew; Elliott, David; Owen, Dawn; Atluri, Namratha; Jolly, Shruti; Chapman, Christina Hunter

Wilkie, Joel R; Lipson, Rachel; Johnson, Matthew C; Williams, Christina; Moghanaki, Drew; Elliott, David; Owen, Dawn; Atluri, Namratha; Jolly, Shruti; Chapman, Christina Hunter.

Afiliação

Wilkie JR; Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Lipson R; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Johnson MC; Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Williams C; Wayne State University School of Medicine, Detroit, Michigan.
Moghanaki D; Cooperative Studies Program Epidemiology Center-Durham, Durham Veterans Affairs Health Care System, Durham, North Carolina.
Elliott D; Department of Medicine, Duke University, Durham, North Carolina.
Owen D; Atlanta Veterans Affairs Health Care System, East Point, Georgia.
Atluri N; Winship Cancer Institute of Emory University, Atlanta, Georgia.
Jolly S; Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Chapman CH; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

Adv Radiat Oncol ; 6(4): 100707, 2021.

Article em En | MEDLINE | ID: mdl-34409207

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Adv Radiat Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google